NDC 54643-5657 - Infuvite Adult
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54643-5657
- Package NDCs from labels
- 54643-5657-1
- Manufacturer
- Sandoz Inc
- Effective date
- 2024-11-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| multiple vitamins injection - Sandoz Inc | Sandoz Inc | 2024-11-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54643-5657-1 | Infuvite Adult | 5 mL in 1 VIAL | INJECTION, SOLUTION | 25 mL | 15 mg in 5mL | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54643-5657 | INFUVITE ADULT (MULTIPLE VITAMINS INJECTION) KIT [SANDOZ INC] | 18 | Unmatched | 20241205_14c7bfc5-07e8-400f-b8ff-5e4794dd2805.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SFERANGS VITA C CAPSULEBOOSTER | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22c67a6-1841-2419-e053-2995a90a9192 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22c9f95-e3ab-bfd3-e053-2995a90a3c66 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d3cad-f8e7-7339-e053-2a95a90af8a4 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN TONER | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d5d31-4c3f-651c-e053-2a95a90ae541 | 2020-03-31 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c097c-82ac-3a21-e053-2995a90a63eb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Rose HeavenCream | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21ba34c-2d2d-8033-e053-2995a90a1d74 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c72f8-00ff-0971-e053-2995a90a2f97 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21cbf42-482c-2d95-e053-2a95a90a1a48 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Emulsion | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d0eba-a96c-72e8-e053-2995a90addfb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright EyeCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d3c87-0a7f-2e15-e053-2a95a90aee69 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightSerum | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d8184-258f-679e-e053-2995a90ad7c4 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Toner | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21daae8-98d6-203a-e053-2a95a90aafe5 | 2020-03-30 | Warnings | 25X51I8RD4 |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Renacidin | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | United-Guardian, Inc. | 13a9bbba-db21-4cba-991c-5d8afaf2ed74 | 2019-12-17 | Warnings, Adverse reactions | XF417D3PSL |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.